This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Health Winners & Losers

Meanwhile, Merck (MRK - Get Report) will build a $297 million facility in Ireland to develop and manufacture vaccines, according to a Reuters report. Its shares were trading up $1.69, or 2.9%, at $59.27.

Elsewhere, BMO Capital downgraded Axcan Pharma (AXCA) to underperform from market perform based on upcoming generic-drug competition. Shares edged down 55 cents, or 3.1%, to $17.37.

In other health stocks, Tenet Healthcare (THC - Get Report) and UnitedHealthcare, a business of UnitedHealth Group (UNH - Get Report) announced a two-year agreement in which UnitedHealthcare members will have access to all acute care hospitals in Tenet's portfolio. The companies didn't disclose financial terms. Tenet's shares rose 42 cents, or 10.5%, to $4.42, while UnitedHealth Group added $1, or 1.9%, to $54.38.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MAXY $0.00 0.00%
MRK $54.81 -0.49%
OSIR $5.01 -6.00%
UNH $132.03 -0.32%
THC $31.46 -1.53%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs